Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR4/ NF-κB pathway and protecting the intestinal barrier. Biomol Biomed [Internet]. 2022 Oct. 23 [cited 2024 May 2];22(6):872-81. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/7348